RAYZEBIO
Live / Applied — Statement of use — non-final action mailed (as of 06 Jan 2026)
What this means for you
Not registered yet, but its 27 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97242231
- Mark type
- Stylized text
- Filed
- 27 Jan 2022
- Published for opposition
- 10 Jan 2023
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use
Owner
- RayzeBio, Inc., San Diego, CA, US
- RayzeBio, Inc., San Diego, CA, US
Prosecution history
- 06 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 20 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jun 2025 — USE AMENDMENT FILED
- 20 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2025 — SOU EXTENSION 4 GRANTED
- 07 Mar 2025 — SOU EXTENSION 4 FILED
- 07 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED